drugset / Trial / NCT06087094
A Trial of HRS-7450 in Chinese Healthy Volunteers
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this First-in-Human study is to evaluate the safety and tolerability after single ascending doses of HRS-7450 given to healthy subjects, compared to placebo..
Timeline
- Start
- 2023-10
- Primary completion
- 2023-12
- Completion
- 2023-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HRS-7450 | Unknown | — | — |